Range Financial Group
GSK icon

Range Financial Group’s GSK GSK Stock Holding History

Range Financial Group’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$759K Sell
15,755
-1,113
-7% -$56.8K 0.21% 114
2026
Q2 		$884K Buy
16,868
+109
+0.7% +$5.76K 0.24% 107
2026
Q1 		$925K Sell
16,759
-281
-2% -$15.2K 0.31% 95
2025
Q4 		$836K Buy
17,040
+515
+3% +$24K 0.29% 101
2025
Q3 		$713K Sell
16,525
-673
-4% -$26.3K 0.26% 107
2025
Q2 		$660K Buy
17,198
+8,063
+88% +$308K 0.26% 106
2025
Q1 		$354K Buy
9,135
+652
+8% +$23.9K 0.16% 135
2024
Q4 		$287K Buy
+8,483
New +$305K 0.13% 154
2024
Q3 		– Sell
-10,895
Closed -$419K – 121
2024
Q2 		$419K Sell
10,895
-124
-1% -$5.22K 0.21% 119
2024
Q1 		$472K Buy
11,019
+1,117
+11% +$46.1K 0.25% 114
2023
Q4 		$367K Sell
9,902
-870
-8% -$31.2K 0.22% 122
2023
Q3 		$390K Sell
10,772
-501
-4% -$17.8K 0.26% 113
2023
Q2 		$402K Sell
11,273
-135
-1% -$4.84K 0.26% 121
2023
Q1 		$406K Buy
11,408
+1,889
+20% +$66.1K 0.27% 122
2022
Q4 		$334K Sell
9,519
-1,197
-11% -$39.9K 0.23% 142
2022
Q3 		$315K Buy
10,716
+1,473
+16% +$55.8K 0.24% 128
2022
Q2 		$503K Sell
9,243
-208
-2% -$11.5K 0.37% 110
2022
Q1 		$515K Buy
9,451
+154
+2% +$8.36K 0.33% 107
2021
Q4 		$512K Buy
9,297
+111
+1% +$5.77K 0.34% 105
2021
Q3 		$439K Buy
9,186
+87
+1% +$4.37K 0.32% 107
2021
Q2 		$453K Buy
9,099
+329
+4% +$15.8K 0.33% 95
2021
Q1 		$391K Buy
+8,770
New +$398K 0.36% 103

Other funds holding GSK

BI Asset Management Fondsmaeglerselskab
BI Asset Management Fondsmaeglerselskab Kobenhavn, Denmark $13.1B AUM 35.37% 1-Year Est. Return
Douglas Lane & Associates
Douglas Lane & Associates New York $7.46B AUM 24.36% 1-Year Est. Return
AssetMark Inc
AssetMark Inc Concord, California $59.5B AUM 15.92% 1-Year Est. Return
Foster Victor Wealth Advisors
Foster Victor Wealth Advisors Greenville, South Carolina $2.02B AUM 20.94% 1-Year Est. Return
Sound Income Strategies
Sound Income Strategies Ft Lauderdale, Florida $2.24B AUM 8.38% 1-Year Est. Return
Euro Pacific Asset Management
Euro Pacific Asset Management Dorado, Puerto Rico $1.22B AUM 22.48% 1-Year Est. Return
Keystone Financial Planning
Keystone Financial Planning Cleveland, Ohio $404M AUM 16.77% 1-Year Est. Return
Bell Bank
Bell Bank Fargo, North Dakota $2.66B AUM 18.07% 1-Year Est. Return
Keating Investment Counselors
Keating Investment Counselors Delray Beach, Florida $382M AUM 16.71% 1-Year Est. Return
Robertson Stephens Wealth Management
Robertson Stephens Wealth Management San Francisco, California $4.14B AUM 13.63% 1-Year Est. Return

Range Financial Group's GSK Position: Q3 2026 in Review

Range Financial Group reduced its GSK (GSK) stake by 6.6% in Q3 2026, selling an estimated $56.8K and leaving 15,755 shares worth $759K. The position accounts for 0.21% of the portfolio, ranked #114.

Range Financial Group first reported a position in GSK in Q1 2021 and has held it in 22 quarters since. The position peaked at $925K in Q1 2026. 215 funds tracked by Wall St. Rank hold GSK as of Q3 2026.

  • Range Financial Group held 15,755 shares of GSK worth $759K as of Q3 2026.
  • Range Financial Group sold 1,113 GSK shares in Q3 2026, an estimated $56.8K.
  • GSK made up 0.21% of Range Financial Group's portfolio in Q3 2026, its #114 holding.
  • Range Financial Group first reported a position in GSK in Q1 2021 and has held it in 22 quarters since.
  • Range Financial Group's GSK position peaked at $925K in Q1 2026.
  • 215 funds tracked by Wall St. Rank held GSK as of Q3 2026.

Based on Range Financial Group's 13F filing for Q3 2026, filed 21 Oct 2026.